These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 228303)

  • 1. Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions.
    Geiger B; Rosenthal KL; Klein J; Zinkernagel RM; Singer SJ
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4603-7. PubMed ID: 228303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
    Bowman MR; Lyles DS; Parce JW
    J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
    Ciavarra R; Forman J
    J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis.
    Tanaka Y; Tevethia SS
    Virology; 1988 Aug; 165(2):357-66. PubMed ID: 2970152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.
    Hale AH; Witte ON; Baltimore D; Eisen HN
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):970-4. PubMed ID: 204941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of simian virus 40 T antigen synthesized during viral lytic cycle in monkey kidney cells expressing mouse H-2Kb- and H-2Db-transfected genes by SV40-specific cytotoxic T lymphocytes leads to the abrogation of virus lytic cycle.
    Bates MP; Jennings SR; Tanaka Y; Tevethia MJ; Tevethia SS
    Virology; 1988 Jan; 162(1):197-205. PubMed ID: 2827378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes.
    Loh D; Ross AH; Hale AH; Baltimore D; Eisen HN
    J Exp Med; 1979 Nov; 150(5):1067-74. PubMed ID: 227980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.
    Ruebush MJ; Hale AH; Harris DT
    Infect Immun; 1981 May; 32(2):513-7. PubMed ID: 6265359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific selection of host cell glycoproteins during assembly of murine leukaemia virus and vesicular stomatitis virus: presence of Thy-1 glycoprotein and absence of H-2, Pgp-1 and T-200 glycoproteins on the envelopes of these virus particles.
    Calafat J; Janssen H; Démant P; Hilgers J; Závada J
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1241-53. PubMed ID: 6133909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
    Roscoe DM; Ishikawa K; Lyles DS
    J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for generating cell membrane antigens that are recognized by cytotoxic T lymphocytes.
    Ciavarra R; Kang CY; Forman J
    Fed Proc; 1981 Feb; 40(2):222-7. PubMed ID: 6257559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of ligand-induced receptor patching and capping using a novel immunolactoperoxidase iodination technique.
    Bourguignon LY
    J Cell Biol; 1979 Dec; 83(3):649-56. PubMed ID: 391811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.